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Abstract
Background—Increases in non-medical use of pharmaceutical opioids in the U.S. have resulted
in increases in opioid dependence and unintentional overdose deaths. We characterize
heterogeneity in opioid use patterns among a community-based sample of 18–23 year-olds who
use non-medical pharmaceutical opioids, yet are not opioid dependent.
Methods—Respondent-driven sampling recruited 390 participants. Latent class analysis
stratified by racial/ethnic group identified subgroups of non-medical opioid users based on: six-
month frequency of use; number of opioid disorder criteria; oral vs. non-oral administration;
number of types of opioids used; use of CNS depressants while under using opioids; and reason
for opioid use. Multinomial logistic regression estimated the significance of covariates in
predicting class membership.
Results—Within whites and non-white groups, three classes emerged that were, generally,
hierarchically ordered with respect to negative characteristics associated with non-medical opioid
use. Within each group, the class with the least negative characteristics also had the highest
proportion of individuals who use opioids only to self-medicate a health problem. Within each
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group’s three classes, a larger proportion who had ≥ 2 opioid abuse and dependence disorder
criteria always coincided with a larger proportion who use opioids ≥ 3 days per week, a larger
proportion who used CNS depressants while under the influence of opioids, and a smaller
proportion who used opioids only to self-medicate.
Conclusion—Differences in patterns of opioid use within each racial/ethnic group of young
people who are not opioid dependent suggest the need for tailored interventions designed to
reduce the risk of transition to opioid dependence.
Keywords
non-medical pharmaceutical opioid use; latent class analysis
1. INTRODUCTION
Pharmaceutical opioids are medically valuable drugs that can be used to treat pain
effectively, when prescribed and used appropriately (Yaksh and Wallace, 2011). Regardless,
the non-medical use of pharmaceutical opioids has increased substantially in the United
States since the late 1990s (Cicero et al., 2005; Drug Abuse Warning Network, 2003;
Johnston et al., 2012). For example, from 2002 to 2010, past month non-medical use of
pharmaceutical opioids increased from 4.1 to 4.5% among 18–25 year-olds (SAMHSA,
2011). The problem is manifest worldwide, including Canada, Australia, and parts of Europe
(Fischer and Rehm, 2007; Hall and Farrell, 2011; Holmes, 2012).
In the United States, increases in non-medical pharmaceutical opioid use have resulted in
increases in opioid dependence and unintentional overdose deaths (Centers for Disease
Control and Prevention, 2011) and increasing risks of heroin initiation (Lankenau et. al.,
2012; Peavy et al., 2012; Siegal et al., 2003). Simultaneously, the number of prescriptions
for opioids has increased substantially (Manchikanti et al., 2010; Paulozzi and Ryan, 2006;
Webster et al., 2011).
To develop effective public health interventions, more data are needed to better understand
the heterogeneity of non-medical pharmaceutical opioid users (Zacny et al., 2003). Previous
studies have described general characteristics, such as sources of opioid diversion (Inciardi
et al., 2009), initiation into non-medical opioid use (Daniulaityte et al., 2006; Lankenau et
al., 2012), motivations for opioid use (Boyd et al., 2006; McCabe et al., 2009), gender
differences in non-medical opioid use (Simoni-Wastila et al., 2004), and HIV risk behaviors
associated (Surratt et al., 2006). Other studies have used latent class analysis (LCA) to
describe the heterogeneity of pharmaceutical opioid users using a range of different
objectives and samples (national and treatment-based; Ghandour et al., 2008; Green et al.,
2011; Monga et al., 2007; Vaughn et al., 2012).
This study describes heterogeneity in the pattern of non-medical pharmaceutical opioid use
(henceforth referred to as “opioids”) among a community-based sample of 18–23 year-olds
who were not opioid dependent and had no history of heroin use or non-medical drug
injection. We also examine how socio-demographic characteristics, use of other drugs,
abuse of, or dependence on, other drugs, pain disorder, and psychiatric comorbidity are
related to class membership (Ghandour et al., 2008). The study uses baseline data from our
three-year natural history project designed to identify characteristics associated with
transition to opioid dependence.
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Respondent-driven sampling (RDS) was used to recruit 390 participants in the Columbus,
Ohio, area between April 2009 and May 2010 (Heckathorn, 1997; 2002). Standard RDS
methods were used, including limiting referrals to three per eligible person and
compensating referrers $15 for each person presenting at the project office for an eligibility
determination (Wang et al., 2005; 2007). Our use of RDS is described in Daniulaityte and
colleagues (2012).
2.2. Eligibility
Eligibility included: 1) being 18–23 years old; 2) self-reporting the non-medical use of
pharmaceutical opioids on five or more occasions in the previous 90 days; 3) expressing
intentions to use pharmaceutical opioids again; 4) residence in the Columbus, OH,
metropolitan area; and 5) identifying opioids s/he reported having used on a pill card similar
to the one used in the National Survey on Drug Use and Health (NSDUH) (Caviness et al.,
2006), except that the card did not have the drug names listed, to help verify the reported use
of opioids. Young adults were deemed ineligible if they met DSM-IV criteria for lifetime
opioid dependence, as ascertained with the DSM-IV Checklist (Forman et al., 2004;
Hudziak et al., 1993), reported heroin use or any illicit injection drug use, had pending
criminal charges, or were involved in formal substance abuse treatment.
2.3. Data collection and measures
Baseline structured questionnaires were administered by trained interviewers in private
offices following completion of an informed consent. Protocols were approved by the
Wright State University IRB. The baseline questionnaire was largely a computer-assisted,
interviewer-administered instrument. Participants were compensated $50 for completing a
1.5–2.5 hour baseline interview.
The questionnaire collected data in a number of areas, including six-month frequency of use
of various drugs. Lifetime opioid abuse and dependence were assessed using the DSM-IV
checklist. The computerized version of the Diagnostic Interview Schedule (CDIS) was used
to ascertain lifetime abuse and dependence on other drugs, mental health disorders and pain
disorder (Robins et al., 1999).
Frequency of drug use was collected through author-generated items employed in previous
studies (Carlson et al., 2005; Falck et al., 2005; Siegal et al., 1998). The frequency of drug
use question was: “During the past six months, how often did you use [drug]?” Response
options ranged from “never/none” to “daily” use. For opioids, responses were collapsed to:
“≤1 days/week” (“low level of use”); “about two days/week;” (corresponding roughly to
“weekend use”); and ≥3 days per week (“greater use”). Other drugs were collapsed to “Yes/
No.” Opioid abuse and dependence disorder criteria were collapsed to < 2 versus ≥ 2. Route
of administration was captured by asking: “In the past six months, how did you most often
use [drug]?” collapsed to oral/non-oral. Number of different types of opioids used was
ascertained by asking if participants had used 12 different opioid types, ranging from
hydrocodone to oxymorphone. Number of types of opioids used were collapsed to ≤ 2
versus >2. To determine the number of lifetime legitimate opioid prescriptions, we asked:
“Have you ever received a prescription for “pain pills” for a health problem you
experienced, like dental pain, broken bones, back pain, or after surgery?” Followed by: ‘In
the past six months, how many times have you been prescribed “pain pills” for a
“legitimate” health problem?’ To determine concurrent use of opioids and alcohol or
tranquilizers, we asked: “In the past 6 months, how often did you use [drug] when you were
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under the influence of “pain pills?” Response options were categorized as “sometimes”
versus “never.” Reasons for opioid use were captured by asking: “In the past 6 months, did
you use ‘pain pills’ illicitly to get ‘high’ “ and/or “to self-medicate a health problem?”
2.4. Statistical analysis
Descriptive statistics (mean and SD, n and %) for all variables were compared across ethnic/
racial groups using t-tests for continuous variables and chi-square tests for categorical
variables (Fisher’s exact test was used when any cell counts were ≤ 5).
Latent class analysis (Lazarsfeld and Henry, 1968; Magidson and Vermunt, 2004) was used
to identify subgroups of opioid users that were heterogeneous with respect to the latent
construct, “pattern of non-medical use of opioids.” The significance of demographic
covariates (age, years since first non-medical use of pain pills, gender, education,
employment, financial resources, relationship status, and residence status) as predictors of
latent class membership were tested using multinomial logistic regression after the LCA was
fit using the 3-step procedure, which takes into account the uncertainty in assigning latent
class membership to individuals (Vermunt 2010, Asparouhov and Muthén, 2012).
Interactions for pairs of significant covariates were tested as well. Hypothesis tests were
conducted at the 0.05 level of significance. Means and proportions of all covariates and
auxiliary variables were then compared across classes using posterior probability-based
multiple imputations (Asparouhov, 2007).
Latent class indicators of “patterns of non-medical opioid use” included: six-month
frequency of use; number of opioid abuse and dependence disorder criteria (< 2 versus ≥ 2);
oral versus non-oral administration; number of different types of opioids used (≤ 2 versus >
2); use of CNS depressants (alcohol or tranquilizers) while under the influence of opioids
(yes/no); and reason for opioid use (“to get high” only; to “self-medicate” only; or both).
Decisions regarding which variables to include as latent class indicators were made based on
goodness of fit of the LCA model. Some auxiliary variables we considered for inclusion as
indicators of the latent construct (e.g., most common source of opioids, ever had a legitimate
opioid prescription, ever sold opioids) were too highly correlated with the other indicators,
resulting in a violation of the local independence assumption; therefore, these were excluded
from indicators. Whether and how to collapse categories was based on model
interpretability. In general, binary variables were preferred and categories were collapsed to
have approximately equal counts in each level, although this was not always possible.
Frequency of opioid use was collapsed to three levels, since a binary split was felt to over-
simplify this variable.
Preliminary analyses demonstrated that there was a lack of measurement invariance between
ethnic/racial groups (non-whites vs. whites). That is, ethnic/racial groups differed not only
quantitatively in terms of their proportions of individuals in different classes, but also
qualitatively—the pattern of large and small within-class conditional probabilities of the
latent class indicators differed between groups. Therefore, distinct LCAs were carried out
for non-whites and whites. For each LCA, we first fit models with differing numbers of
classes. The choice of the optimal number of classes was based on: a) the statistical criteria
Akaike’s Information Criterion (AIC), Bayesian Information Criterion (BIC), and the
Bootstrap Likelihood Ratio Test (BLRT); b) latent class separation; c) homogeneity; d) local
independence; and e) interpretability (Collins and Lanza, 2010). Lower AIC and BIC are
preferred, as is a BLRT p-value < 0.05 (indicating rejection of the null hypothesis that a K-1
class model is sufficient where the alternative hypothesis is that a K class model is
necessary). Latent class separation and homogeneity are subjective judgments about the
distinctness (between classes) of the conditional distributions of the indicators and about the
similarity of response patterns between individuals within classes, respectively. Latent class
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separation is greatest when response patterns with high probability in one class have low
probability in other classes. Homogeneity is greatest when, within a class, all conditional
probabilities are either 0 or 1 (Collins and Lanza, 2010). Local independence states that the
indicators are independent given the latent classes and is the primary assumption of an LCA.
Within-class pairwise independence was assessed by computing bivariate residuals and then
summarizing them as a bivariate chi-square statistic (BVCS). A BVCS > 2 indicates that the
local independence assumption may be violated for that pair of indicators.
Latent class prevalences were computed based on estimated posterior probabilities, not
simply based on each individual’s most likely class membership. The LCA, the multinomial
logistic regression, and the comparison of means and proportions across classes were carried
out simultaneously in Mplus 7 (Muthén and Muthén, 2012).
3. RESULTS
3.1. Socio-demographic characteristics and indicator, covariate, and auxiliary variable
distributions
Socio-demographic characteristics, covariates, and auxiliary variables overall and by ethnic/
racial grouping (referred to as “group”) are presented in Table 1. The mean age was 21.0
years, and 54.6% were men. Whites (192) constituted 49.2% of the sample; among the 198
non-whites, 88.4% were African American, 3.0% Hispanic/Latino, 3.0% Asian/Pacific
Islander, 5.1% were biracial (African American/other), and one was Somali/white.
On average, participants had been using opioids non-medically for about four years, with a
mean age of initiation of 16.9 years. In the previous six months, immediate-release
oxycodone products were the most commonly used opioids (92.3%), followed by
hydrocodone (83.6%), oxycodone (29.0%), codeine (25.9%), morphine (7.7%), “other pain
medication” (7.7%), hydromorphone (6.7%), methadone (6.4%), buprenorphine/naloxone -
sublingual (4.4%), fentanyl (1.3%), and oxymorphone (0.3%). Indicator variables and their
descriptions are presented in Table 2.
White and non-white groups differed on a number of variables (Tables 1 and 2). For
example, six-month frequency of opioid use and the proportion administering opioids orally
was greater among non-whites (p<0.001; Table 2). The proportions of individuals who used
more than two kinds of opioids (p=0.003) and who used opioids and other CNS depressants
were greater among whites (p=0.016).
3.2. Optimal number of latent classes
Model selection criteria did not unanimously point to the same optimal number of classes.
For both groups, the four-class model was ruled out based on higher (worse) AIC and BIC,
and failure of the BLRT to reject the null hypothesis that a three-class model is sufficient.
For both groups, the three-class model was preferred to the two-class model based on better
adherence to the local independence assumption, with only two BVCS > 2 for the three-class
model for whites and no BVCS > 2 for the three-class model for non-whites, but 4 (whites)
or 2 (non-whites) pairs of indicators exhibiting a BVCS > 2 for each of the two-class
models. Additionally, the three-class models exhibited adequate latent class separation and
homogeneity and were highly interpretable. Therefore, the three-class models were chosen.
3.3. Conditional probabilities of latent class indicators and latent class definitions
The within-class distributions of the latent class indicators are shown in Table 3, by ethnic/
racial group. The within-group class numbering (1 to 3) reflects a rough ordering of the
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groups from most to least negative pattern of opioid use. Individual conditional probabilities
differ between groups, and their joint distributions differ markedly.
Among non-whites, Class NW-1 has more negative characteristics, with larger proportions
of individuals having a high frequency of opioid use, having ≥ 2 opioid disorder criteria,
who have used > 2 different kinds of opioids, and who have used CNS depressants with
opioids. Not all those in Class NW-1 have a high frequency of use, however, with 27%
using < 2 days per week. Class NW-2 is characterized by having a large proportion (87%) of
individuals who use opioids about two days per week, and low proportions with ≥ 2 opioid
disorder criteria or use of other CNS depressants with opioids. Class NW-3 is characterized
by the least negative characteristics, with 100% using opioids < 2 days per week, none with
≥ 2 opioid disorder criteria, and little use of CNS depressants with opioids. Almost everyone
in the NW classes used opioids orally.
Class W-1 is similar in some ways to Class NW-1 with generally more negative
characteristics than the other white classes. Class W-1 is distinguished from the other classes
by having the lowest proportion using < 2 days per week, highest proportion with ≥ 2 opioid
abuse and dependence disorder criteria, highest proportion using other CNS depressants
with opioids, and 100% reporting use to “get high and self-medicate.” Class W-2 has a mix
of individuals who use opioids < 2 days per week (62%) and individuals who use opioids ≥
3 days per week (29%). Rather than being distinguished by frequency of use, Class W-2 is
characterized by having a very low proportion (30%) of individuals who use opioids orally,
a high proportion using more than two different kinds of opioids, a high proportion who use
CNS depressants while under the influence of opioids, and 99% using opioids to get high
only. Class W-3 is characterized by having the least negative characteristics, including low
frequencies of opioid use, a low proportion with ≥ 2 opioid disorder criteria, and almost all
reporting oral opioid use.
3.4. Predictors of latent class membership
Based on the results of the multinomial logistic regression, the significant predictors of
latent class membership were age (both groups) and education (whites only; Table 4). The
age × education interaction was not significant.
3.5. Comparison of covariates and auxiliary variables between classes
Compared to other NW classes, participants in Class NW-1 had a significantly larger mean
number of days drunk in the previous 30 days, larger proportions having mental health
disorders, higher proportions using other drugs such as marijuana and MDMA, and higher
proportions having alcohol abuse or dependence or marijuana dependence (Table 5). Within
each group, the class with the least negative characteristics (NW-3 and W-3) had higher
proportions who obtained opioids for free or left over from legitimate prescriptions,
although this difference was only significant within whites. In other words, individuals in
classes with more negative characteristics were more likely to buy or steal opioids from
others or “doctor shop.”
Among whites, participants in class W-2 were more likely to use several other substances
(Table 5). The white classes differed significantly in their proportions of individuals with
pain, with almost 90% of those in Class W-1 (the class with 100% using to self-medicate)
reporting having pain. Proportions reporting having pain were high regardless of group or
class, ranging from 75% to 83% among non-whites and 69% to 89% among whites.
However, classes within groups did not differ significantly in having pain disorder.
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Our findings indicate that the pattern of non-medical use of opioids among non-opioid
dependent young adults varied both between and within ethnic/racial groups. Within each
group, we found three subgroups that were, in general, hierarchically ordered with respect to
negative characteristics associated with opioid use. Within each group, the class with the
least negative characteristics (NW-3 and W-3) is also the class which has the highest
proportion of individuals who use opioids only to self-medicate a health problem. Within
each group’s three classes, a larger proportion who have ≥ 2 opioid disorder criteria always
coincided with: a larger proportion who use opioids ≥ 3 days per week, a larger proportion
who used other CNS depressants while under the influence of opioids, and a smaller
proportion who use only to self-medicate (and almost always coincided with a larger
proportion who used more than two types of opioids). Between groups, however, there were
differences in the distinctions between class characteristics and frequency.
Interestingly, almost all the non-whites administered opioids orally, while there was some
variation among whites. Class W-2 had the highest rate of non-oral opioid administration
(snorting) and also had the highest proportion of individuals using opioids to get high only.
Non-whites had no group with these characteristics. Higher proportions of snorting opioids
among whites is consistent with higher proportions reporting cocaine and other stimulant
use, which are often snorted.
Those who were older (both groups) were more likely to be in classes having more negative
characteristics (NW-1; W-1). Although not statistically significant, those in classes with
more negative characteristics had been using opioids to get high for a longer period of time,
as expected.
Comparison of covariates and auxiliary variables across the latent classes provides
additional insight into the differences between these classes, although we are unable to
ascribe causality in either direction (Table 5). For example, we cannot conclude that poorer
mental health causes increased non-medical opioid use or vice versa, only that such an
association was observed among non-whites in our sample. Unlike one prior study finding
gender to be an important factor in predicting characteristics of opioid users (Wu et al.,
2010; Green et al., 2011), gender had no significant association with the identified classes.
The illegal use of opioids coupled with other CNS depressants, like alcohol and
benzodiazepines, can be life-endangering (e.g., Jones et al., 2012). Members of classes
NW-1 as well as W-1 and W-2 had high proportions of concomitant use of opioids and CNS
depressants placing them at high risk of potential overdoses.
Our findings contrast substantially with other studies of opioid users, in part, by the
comparatively high representation of non-whites, the vast majority of whom were African
American. Based on prior literature, we did not anticipate recruiting a high proportion of
African Americans, but our assessment of RDS (Daniulaityte et al., 2012) suggests a high
level of in-group recruitment among whites and African Americans, suggesting high levels
of social distance. Importantly, this social distance is validated by our LCA that found
significant “qualitative” differences between whites and non-whites. Findings indicate there
may, in fact, be more nonmedical pharmaceutical opioid use among young African
Americans than previously indicated by national epidemiologic monitoring, at least in the
study location.
In a study with college students, McCabe and colleagues (2009) found that self-treatment of
pain was more prevalent among African Americans, while recreational use was more
common among white opioid users. Overall, ethnic/racial groups in our study did not differ
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in motivations for use (Table 2). However, in our study, which was not limited to college
students, among whites, higher education was a predictor of being more likely to be in class
W-2 compared to W-3, and class W-2 was comprised almost entirely of individuals who use
opioids only to get high (recreational use as defined by McCabe and colleagues (2009).
McCabe and colleagues (2009) hypothesized that using opioids to self-treat pain would be
associated with fewer substance abuse problems, compared to recreational (equivalent of our
“to get high” category) or “mixed” (recreational and self-treatment) users. This was
supported in their study, and was supported in ours, as well. Among whites and non-whites,
the classes with the highest proportion of individuals who use opioids only to self-medicate
(NW-3 and W-3) had the least negative characteristics associated with opioid use. Also,
consistent with their study, members of classes NW-1, W-1, and W-2 who used opioids to
get high or to get high and self-medicate, also had higher levels of negative characteristics as
McCabe and colleagues (2009) hypothesized. The significance of reasons for opioid use
reinforces prior suggestions of the need for population-based epidemiological surveys to
differentiate non-medical pharmaceutical opioid users by their motivations of use, which
could influence intervention approaches (Zacny and Lichtor, 2008).
Regardless of group or class, proportions of members reporting having pain in our study
were consistently high, ranging from 69% to 89%, although Class W-1 had significantly
higher levels of pain, compared to Classes W-2 and W-3. High levels of having pain across
classes may explain why proportions having pain disorder did not differentiate subgroups.
Passik and colleagues (2006) also found a high proportion of prescription drug users
(n=109) having pain (76%) upon entering substance abuse treatment in Kentucky. In a study
of 237 community-based opioid users recruited in Maine (Heimer et al., 2012), 40%
reported pain that interfered with their daily lives. We need to further differentiate the
reasons participants in our study reported having pain.
Findings from other LCA analyses of opioid users differ substantially from ours because of
differences in samples and study objectives. However, some similarities are noted. Based on
NSDUH data, one study used LCA to identify heterogeneity of risk among 1,783
adolescents (12–17 years) reporting lifetime use of non-medical opioids (Vaughn et al.,
2012). The four classes identified were generally hierarchically ordered with respect to
levels of risk and substance use (although quite different indicators were used). While we
also found a hierarchical ranking of classes with respect to negative characteristics
associated with opioid use among classes, our study is based on young adults who were
actively involved with non-medical use of opioids. In addition, Vaughn and colleagues
(2009) found that African Americans were more likely than whites to be members of a high
delinquency and low substance use class but less likely to be members of a high risk and
high substance use/low delinquency class. In contrast, Class NW-1 is characterized by high
frequencies of opioid and other drug use and negative characteristics associated with opioid
use.
Limitations are noted. Our study was conducted in the Midwest U.S., so the findings may
not be generalizable to other areas. Second, we attempted to make the sample as
representative as possible by using respondent-driven sampling, but it may contain biases,
including those related to employment and income levels. In addition, we lack a reliable
measure of socioeconomic status; the recruited sample was very young, and some
participants were still financially dependent on their families, making assessment
complicated. Third, the age range of the sample was limited to 18–23 year-olds to capture
those who arguably are at greater risk for opioid misuse and at risk of transition to
dependence. Fourth, the use of a geographic indicator auxiliary variable may have provided
some insight into the class distinctions, but we lack one that is meaningful. Finally, the
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findings are based on self-report, but there is substantial support for the validity of self-
report data (Adair et al., 1995; Darke, 1998).
In summary, our study provides new information about the heterogeneity of illicit opioid
users who represent an age group (18–23) with the highest rates of illicit opioid use. Since
our study focused on a community-based sample of non-medical users who were not opioid
dependent (DSM-IV) and non-injectors, study findings can help tailor early interventions to
address the unique needs and differential levels of risks associated with illicit opioid use.
Young, non-dependent illicit pharmaceutical opioid users are an important population for
interventions designed to reduce the risk of transition to opioid dependence, possible
transition to heroin use, and unintentional overdose death. Future studies will identify
characteristics associated with increases in opioid dependence criteria and transition to
heroin, over three years.
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Table 4
Odds ratios (95% confidence intervals) for significant predictors of latent class membership (significant odds
ratios, p ≤ 0.05, are in bold; all significant predictors (covariates) are in the model simultaneously).
Variable NW-1 vs. NW-2 NW-1 vs. NW-3 NW-2 vs. NW-3
Age (years) 1.27 (1.01, 1.60) 1.32 (1.01, 1.72) 1.04 (0.78, 1.37)
W-1 vs. W-2 W-1 vs. W-3 W-1 vs. W-3
Age (years) 1.31 (1.00, 1.70) 1.04 (0.77, 1.42) 0.80 (0.61, 1.04)
Education (Some college) 0.77 (0.33, 1.81) 1.96 (0.81, 4.78) 2.55 (1.01, 6.46)
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Drug Alcohol Depend. Author manuscript; available in PMC 2015 January 01.
